Lack of a functional AMBN in the bone matrix resulted in 31% decreased femur bone mass and 40% reduced energy to failure.
AMBN function inhibition diminished the proliferative capacity of fracture repair callus cells.
AMBN truncation was associated with an enhanced and prolonged chondrogenic phase.
There was a 6.9-fold increase in AMBN expression at the fracture site one week after fracture.
Application of exogenous AMBN protein to bone fracture sites accelerated callus formation and bone fracture healing.